Multiplex polymerase chain reaction: A practical approach

Journal of Clinical Laboratory Analysis - Tập 16 Số 1 - Trang 47-51 - 2002
Panayotis Markoulatos1, Nikolaos Siafakas1, Maurice L.J. Moncany2
1Virology Department, Hellenic Pasteur Institute, Athens, Greece
2Laboratoire de Biologie Cellulaire et Moléculaire, Université de La Rochelle, La Rochelle, France

Tóm tắt

Abstract

Considerable time and effort can be saved by simultaneously amplifying multiple sequences in a single reaction, a process referred to as multiplex polymerase chain reaction (PCR). Multiplex PCR requires that primers lead to amplification of unique regions of DNA, both in individual pairs and in combinations of many primers, under a single set of reaction conditions. In addition, methods must be available for the analysis of each individual amplification product from the mixture of all the products. Multiplex PCR is becoming a rapid and convenient screening assay in both the clinical and the research laboratory. The development of an efficient multiplex PCR usually requires strategic planning and multiple attempts to optimize reaction conditions. For a successful multiplex PCR assay, the relative concentration of the primers, concentration of the PCR buffer, balance between the magnesium chloride and deoxynucleotide concentrations, cycling temperatures, and amount of template DNA and Taq DNA polymerase are important. An optimal combination of annealing temperature and buffer concentration is essential in multiplex PCR to obtain highly specific amplification products. Magnesium chloride concentration needs only to be proportional to the amount of dNTP, while adjusting primer concentration for each target sequence is also essential. The list of various factors that can influence the reaction is by no means complete. Optimization of the parameters discussed in the present review should provide a practical approach toward resolving the common problems encountered in multiplex PCR (such as spurious amplification products, uneven or no amplification of some target sequences, and difficulties in reproducing some results). Thorough evaluation and validation of new multiplex PCR procedures is essential. The sensitivity and specificity must be thoroughly evaluated using standardized purified nucleic acids. Where available, full use should be made of external and internal quality controls, which must be rigorously applied. As the number of microbial agents detectable by PCR increases, it will become highly desirable for practical purposes to achieve simultaneous detection of multiple agents that cause similar or identical clinical syndromes and/or share similar epidemiological features. J. Clin. Lab. Anal. 16:47–51, 2002. © 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1093/nar/16.23.11141

Rithidech KN, 1997, Combining multiplex and touch down PCR to screen murine microsatellite polymorphisms, BioTechniques, 23, 36, 10.2144/97231bm06

10.1093/hmg/2.2.153

Zimmermann KD, 1996, Quantitative multiple competitive PCR of HIV‐1 DNA in a single reaction tube, BioTechniques, 21, 480, 10.2144/96213st06

Crisan D, 1994, Molecular diagnostic testing for determination of myeloid lineage in acute leukemias, Ann Clin Lab Sci, 24, 355

10.1016/S0928-0197(96)00255-3

10.1002/(SICI)1096-9071(199902)57:2<145::AID-JMV10>3.0.CO;2-N

10.1002/(SICI)1098-2825(1999)13:3<99::AID-JCLA2>3.0.CO;2-E

Markoulatos P, 2000, Detection of sheep poxvirus in skin biopsy samples by a multiplex polymerase chain reaction, J Virol Methods, 14, 214

10.1002/1098-2825(2000)14:5<214::AID-JCLA3>3.0.CO;2-4

10.1128/JCM.35.11.2854-2858.1997

Harris E, 1998, Single step multiplex PCR assay for characterization of New World Leishmania complexes, J Clin Microbiol, 36, 1989, 10.1128/JCM.36.7.1989-1995.1998

10.1093/nar/17.13.5407

10.1093/nar/25.16.3235

10.1093/nar/20.7.1717

10.2144/97233rr01

10.1093/nar/23.8.1411

10.1093/sysbio/43.2.250

10.1016/0166-0934(95)01903-0

10.1128/JCM.36.10.2990-2995.1998

10.1128/CMR.13.4.559-570.2000

10.1038/labinvest.3780299

10.1002/humu.1380060207

10.1046/j.1365-2257.2000.00265.x

10.1016/S1246-7820(01)00141-0

10.1038/labinvest.3780320

10.1128/JCM.39.2.696-704.2001